CD274 and nonpapillary renal cell carcinoma: PD-L1+ frequency was numerically lower yet not significantly different in FOLH1-high compared to FOLH-low tumors among patients with ccRCC (10% versus 17%, respectively, p = 0.07) but was similar among non-ccRCC tumors (31% versus 32%, respectively, p = 0.95).